In this session, Dr. Cheshire will discuss how to accurately assess patients in pain, develop a safe and effective pain treatment plan, identify evidence-based non-opioid options for the treatment of pain, and recognize behaviors that may be associated with opioid use disorder. Session participants will also learn to identify the risks and benefits of opioid therapy and how to manage ongoing therapy with patients.
This course meets the Drug Enforcement Agency (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) Medication Access and Training Expansion (MATE) Act. The Act requires new or renewing DEA registrants, as of June 27, 2023, to have completed a total of at least eight hours of training on opioid or other substance use disorders.
- Describe the pathophysiology of pain as it relates to the concepts of pain management
- Accurately assess patients in pain
- Develop a safe and effective pain treatment plan
- Identify evidence-based non-opioid options for the treatment of pain
- Identify the risks and benefits of opioid therapy
- Manage ongoing opioid therapy
- Identify behaviors that may be associated with opioid use disorder
Start Date: February 6, 2024
End Date: February 5, 2027
This course has been approved for 2.0 AOA Category 1-A CME Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies (RPC). This activity is intended to be fully-compliant with the Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).